P
Paolo Airò
Researcher at University of Brescia
Publications - 287
Citations - 11480
Paolo Airò is an academic researcher from University of Brescia. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 53, co-authored 250 publications receiving 9588 citations.
Papers
More filters
Journal ArticleDOI
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
A Tyndall,Bettina Bannert,Madelon C. Vonk,Paolo Airò,Franco Cozzi,Patricia Carreira,Dominique Farge Bancel,Yannick Allanore,Ulf Müller-Ladner,Oliver Distler,Florenzo Iannone,Raffaele Pellerito,Margarita Pileckyte,I. Miniati,L. Ananieva,Alexandra Balbir Gurman,Nemanja Damjanov,Adelheid Mueller,Gabriele Valentini,Gabriela Riemekasten,Mohammed Tikly,Laura K. Hummers,Maria João Henriques,Paola Caramaschi,Agneta Scheja,Blaz Rozman,Evelien Ton,Gábor Kumánovics,Bernard Coleiro,Eva Feierl,Gabriella Szücs,Carlos Alberto Von Mühlen,Valeria Riccieri,Srdan Novak,Carlo Chizzolini,Anna Kotulska,Christopher P. Denton,Paulo C. Coelho,Ina Kötter,Ismail Simsek,Paloma García de la Peña Lefebvre,Eric Hachulla,James R. Seibold,Simona Rednic,Jiri Stork,Jadranka Morović-Vergles,Ulrich A. Walker +46 more
TL;DR: Disease-related causes, in particular pulmonary fibrosis, PAH and cardiac causes, accounted for the majority of deaths in SSc.
Journal ArticleDOI
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.
Paola Toniati,Simone Piva,Marco Cattalini,Emirena Garrafa,Francesca Regola,Francesco Castelli,Franco Franceschini,Paolo Airò,Chiara Bazzani,Eva Andrea Beindorf,Marialma Berlendis,Michela Bezzi,Nicola Bossini,Maurizio Castellano,Sergio Cattaneo,Ilaria Cavazzana,Giovanni Battista Contessi,Massimo Crippa,Andrea Delbarba,Elena De Peri,Angela Faletti,Matteo Filippini,Micol Frassi,Mario Gaggiotti,Roberto Gorla,Michael J. Lanspa,Silvia Lorenzotti,Rosa Marino,Roberto Maroldi,Marco Metra,Alberto Matteelli,Denise Modina,Giovanni Moioli,Giovanni Montani,Maria Lorenza Muiesan,Silvia Odolini,Elena Peli,Silvia Pesenti,Maria Chiara Pezzoli,Ilenia Pirola,Alessandro Pozzi,Alessandro Proto,Francesco Antonio Rasulo,Giulia Renisi,Chiara Ricci,Damiano Rizzoni,Giuseppe Romanelli,Mara Rossi,Massimo Salvetti,Francesco Scolari,Liana Signorini,Marco Taglietti,Gabriele Tomasoni,Lina Rachele Tomasoni,Fabio Turla,Alberto Valsecchi,Davide Zani,Francesco Zuccalà,Fiammetta Zunica,Emanuele Focà,Laura Andreoli,Nicola Latronico +61 more
TL;DR: It was showed that COVID-19 pneumonia with ARDS was characterized by HIS, and the response to TCZ was rapid, sustained, and associated with significant clinical improvement.
Journal ArticleDOI
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
Timothy R D J Radstake,Olga Y. Gorlova,Blanca Rueda,Jose Ezequiel Martin,Behrooz Z. Alizadeh,Rogelio Palomino-Morales,Marieke J H Coenen,Madelon C. Vonk,Alexandre E. Voskuyl,Annemie J. Schuerwegh,Jasper C A Broen,Piet L. C. M. van Riel,Ruben van 't Slot,Annet Italiaander,Roel A. Ophoff,Roel A. Ophoff,Gabriela Riemekasten,Nico Hunzelmann,Carmen P. Simeon,Norberto Ortego-Centeno,Miguel A. Gonzalez-Gay,María Francisca González-Escribano,Paolo Airò,Jaap M van Laar,Ariane L. Herrick,Jane Worthington,Roger Hesselstrand,Vanessa Smith,Filip De Keyser,Fredric Houssiau,Meng May Chee,Rajan Madhok,Paul G. Shiels,Rene Westhovens,Alexander Kreuter,Hans P. Kiener,Elfride De Baere,Torsten Witte,Leonid Padykov,Lars Klareskog,Lorenzo Beretta,Rafaella Scorza,Benedicte A. Lie,Anna Maria Hoffmann-Vold,Patricia Carreira,John Varga,Monique Hinchcliff,Peter K. Gregersen,Annette Lee,Jun Ying,Younghun Han,Shih-Feng Weng,Christopher I. Amos,Fredrick M. Wigley,Laura K. Hummers,J. Lee Nelson,Sandeep K. Agarwal,Shervin Assassi,Pravitt Gourh,Filemon K. Tan,Bobby P. C. Koeleman,Frank C. Arnett,Javier Martín,Maureen D. Mayes +63 more
TL;DR: The first genome-wide association study in a population of European ancestry including a total of 2,296 individuals with SSc and 5,171 controls identified a new susceptibility locus for systemic sclerosis at CD247 (1q22–23, rs2056626).
Journal ArticleDOI
Mapping and predicting mortality from systemic sclerosis
Muriel Elhai,Christophe Meune,Marouane Boubaya,Jérôme Avouac,Eric Hachulla,Alexandra Balbir-Gurman,Gabriela Riemekasten,Paolo Airò,Beatriz Joven,Serena Vettori,Franco Cozzi,Susanne Ullman,László Czirják,Mohammed Tikly,Ulf Müller-Ladner,Paola Caramaschi,Oliver Distler,Florenzo Iannone,L. Ananieva,Roger Hesselstrand,R. Becvar,Armando Gabrielli,Nemanja Damjanov,Maria João Salvador,Valeria Riccieri,Carina Mihai,Gabriella Szücs,Ulrich A Walker,Nicolas Hunzelmann,Duska Martinovic,Vanessa Smith,Carolina de Souza Müller,Carlomaurizio Montecucco,Daniela Opris,Francesca Ingegnoli,Panayiotis G. Vlachoyiannopoulos,Bojana Stamenkovic,Edoardo Rosato,Stefan Heitmann,Jörg H W Distler,Thierry Zenone,Matthias Seidel,Alessandra Vacca,Ellen De Langhe,Srdan Novak,Maurizio Cutolo,Luc Mouthon,Jörg Henes,Carlo Chizzolini,Carlos Alberto Von Mühlen,Kamal Solanki,Simona Rednic,Lisa K. Stamp,Branimir Anić,Branimir Anić,Vera Ortiz Santamaria,Maria De Santis,Sule Yavuz,Walter Alberto Sifuentes-Giraldo,Emmanuel Chatelus,Jiri Stork,Jacob M van Laar,Esthela Loyo,Paloma García de la Peña Lefebvre,Kilian Eyerich,Vanesa Cosentino,Juan José Alegre-Sancho,Otylia Kowal-Bielecka,Grégoire Rey,Marco Matucci-Cerinic,Yannick Allanore +70 more
TL;DR: Combining two complementary and detailed databases enabled the collection of an unprecedented 3700 deaths, revealing the major contribution of the cardiopulmonary system to SSc mortality.
Journal ArticleDOI
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Suzana Jordan,Jörg H W Distler,Britta Maurer,Dörte Huscher,Jacob M van Laar,Yannick Allanore,Oliver Distler,Tore K Kvien,Paolo Airò,Juan José Alegre Sancho,Lidia Ananjeva,Codrina Michaela Ancuta,Martin Aringer,Alexandra Balbir-Gurman,Francesco Paolo Cantatore,Paola Caramaschi,Emmanuel Chatelus,Veronica Codullo,Dominique Farge-Bancel,Rosario Foti,Armando Gabrielli,Jörg Henes,I. Herrgott,Florenzo Iannone,Francesca Ingegnoli,Esthela Loyo,Marco Matucci-Cerinic,Walid Ahmed Abdel Atty Mohamed,Ulf Müller-Ladner,Øyvind Palm,Sergiu Popa,Gabriela Riemekasten,Simona Rednic,Edoardo Rosato,M. Saracco,Agneta Scheja,Vanessa Smith,Carina Mihai,Gabriela Szucs,Matija Tomšič,Gabriele Valentini,Ulrich A. Walker,Rene Westhovens,Sule Yavuz,Thierry Zenone +44 more
TL;DR: The comparison of RTX treated versus untreated matched-control SSc patients from the EUSTAR cohort demonstrated improvement of skin fibrosis and prevention of worsening lung fibrosis, supporting the therapeutic concept of B cell inhibition in SSc.